Nisa Investment Advisors
EGRX

Nisa Investment Advisors’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Nisa Investment Advisors’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-410
Closed -$6.47K – 2783
2023
Q3 		$6.47K Sell
410
-1,240
-75% -$22.3K ﹤0.01% 2256
2023
Q2 		$32.1K Buy
1,650
+1,240
+302% +$29.4K ﹤0.01% 1911
2023
Q1 		$12K Hold
410
– – ﹤0.01% 2138
2022
Q4 		$12K Hold
410
– – ﹤0.01% 2180
2022
Q3 		$13K Sell
410
-207
-34% -$7.59K ﹤0.01% 2154
2022
Q2 		$27K Buy
617
+70
+13% +$3.21K ﹤0.01% 1959
2022
Q1 		$27K Sell
547
-2,538
-82% -$122K ﹤0.01% 1992
2021
Q4 		$142K Buy
3,085
+50
+2% +$2.59K ﹤0.01% 1386
2021
Q3 		$169 Sell
3,035
-1,437
-32% -$70.7K ﹤0.01% 1471
2021
Q2 		$191 Sell
4,472
-1,000
-18% -$41.3K ﹤0.01% 1426
2021
Q1 		$228 Hold
5,472
– – ﹤0.01% 1442
2020
Q4 		$255K Buy
5,472
+3,098
+130% +$145K ﹤0.01% 1368
2020
Q3 		$101K Buy
+2,374
New +$104K ﹤0.01% 1544

Other funds holding EGRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Nisa Investment Advisors's EGRX Position: Q4 2023 in Review

Nisa Investment Advisors sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q4 2023, closing a stake of 410 shares — an estimated $6.47K sold.

Nisa Investment Advisors first reported a position in EGRX in Q3 2020 and held it in 13 quarters. The position peaked at $255K in Q4 2020. 104 funds tracked by Wall St. Rank hold EGRX as of Q4 2023.

  • Nisa Investment Advisors reported no remaining Eagle Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
  • Nisa Investment Advisors sold 410 Eagle Pharmaceuticals, Inc. shares in Q4 2023, an estimated $6.47K.
  • Nisa Investment Advisors first reported a position in Eagle Pharmaceuticals, Inc. in Q3 2020 and held it in 13 quarters.
  • Nisa Investment Advisors's Eagle Pharmaceuticals, Inc. position peaked at $255K in Q4 2020.
  • 104 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q4 2023.

Based on Nisa Investment Advisors's 13F filing for Q4 2023, filed 25 Jan 2024.